Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 1
1961 2
1962 3
1963 3
1964 5
1965 5
1966 2
1968 1
1969 2
1970 3
1971 2
1972 2
1973 2
1974 8
1975 2
1976 12
1977 12
1978 12
1979 3
1980 11
1981 8
1982 9
1983 12
1984 7
1985 12
1986 20
1987 17
1988 23
1989 17
1990 15
1991 22
1992 16
1993 22
1994 29
1995 23
1996 15
1997 27
1998 16
1999 14
2000 11
2001 10
2002 7
2003 7
2004 10
2005 19
2006 13
2007 15
2008 23
2009 14
2010 12
2011 17
2012 14
2013 13
2014 17
2015 21
2016 20
2017 28
2018 21
2019 20
2020 38
2021 36
2022 27
2023 25
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

808 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial Comparing Nanoparticle Albumin-Bound Paclitaxel With Docetaxel for Previously Treated Advanced NSCLC.
Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I. Yoneshima Y, et al. Among authors: takeshita m. J Thorac Oncol. 2021 Sep;16(9):1523-1532. doi: 10.1016/j.jtho.2021.03.027. Epub 2021 Apr 27. J Thorac Oncol. 2021. PMID: 33915251 Free article. Clinical Trial.
Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.
Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, Ando T, Nakayama Y, Okuzono Y, Takiguchi M, Kurisu R, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T. Tasaki S, et al. Among authors: takeshita m. Nat Commun. 2018 Jul 16;9(1):2755. doi: 10.1038/s41467-018-05044-4. Nat Commun. 2018. PMID: 30013029 Free PMC article.
Experimental and Clinical Investigation of Cytokines in Migraine: A Narrative Review.
Yamanaka G, Hayashi K, Morishita N, Takeshita M, Ishii C, Suzuki S, Ishimine R, Kasuga A, Nakazawa H, Takamatsu T, Watanabe Y, Morichi S, Ishida Y, Yamazaki T, Go S. Yamanaka G, et al. Among authors: takeshita m. Int J Mol Sci. 2023 May 6;24(9):8343. doi: 10.3390/ijms24098343. Int J Mol Sci. 2023. PMID: 37176049 Free PMC article. Review.
Prognostic Value of Computed Tomography in Empyema: A Multicenter Retrospective Cohort Study.
Shiroshita A, Kimura Y, Yamada A, Shirakawa C, Yue C, Suzuki H, Anan K, Sato K, Nakashima K, Takeshita M, Okuno T, Nitawaki T, Suzuki H, Igei H, Suzuki J, Tomii K, Ohgiya M, Kataoka Y. Shiroshita A, et al. Among authors: takeshita m. Ann Am Thorac Soc. 2023 Jun;20(6):807-814. doi: 10.1513/AnnalsATS.202210-868OC. Ann Am Thorac Soc. 2023. PMID: 37166901
Potent neutralizing broad-spectrum antibody against SARS-CoV-2 generated from dual-antigen-specific B cells from convalescents.
Takeshita M, Fukuyama H, Kamada K, Matsumoto T, Makino-Okamura C, Lin Q, Sakuma M, Kawahara E, Yamazaki I, Uchikubo-Kamo T, Tomabechi Y, Hanada K, Hisano T, Moriyama S, Takahashi Y, Ito M, Imai M, Maemura T, Furusawa Y, Yamayoshi S, Kawaoka Y, Shirouzu M, Ishii M, Saya H, Kondo Y, Kaneko Y, Suzuki K, Fukunaga K, Takeuchi T; Keio Donner Project. Takeshita M, et al. iScience. 2023 Jun 16;26(6):106955. doi: 10.1016/j.isci.2023.106955. Epub 2023 May 25. iScience. 2023. PMID: 37288342 Free PMC article.
Role of Neuroinflammation and Blood-Brain Barrier Permutability on Migraine.
Yamanaka G, Suzuki S, Morishita N, Takeshita M, Kanou K, Takamatsu T, Suzuki S, Morichi S, Watanabe Y, Ishida Y, Go S, Oana S, Kashiwagi Y, Kawashima H. Yamanaka G, et al. Among authors: takeshita m. Int J Mol Sci. 2021 Aug 19;22(16):8929. doi: 10.3390/ijms22168929. Int J Mol Sci. 2021. PMID: 34445635 Free PMC article. Review.
Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells.
Kojima M, Suzuki K, Takeshita M, Ohyagi M, Iizuka M, Yamane H, Koga K, Kouro T, Kassai Y, Yoshihara T, Adachi R, Hashikami K, Ota Y, Yoshimoto K, Kaneko Y, Morita R, Yoshimura A, Takeuchi T. Kojima M, et al. Among authors: takeshita m. Commun Biol. 2023 May 9;6(1):500. doi: 10.1038/s42003-023-04874-3. Commun Biol. 2023. PMID: 37161050 Free PMC article.
808 results